OrganTech
Promoting Quality Health through Dental and Hair Regeneration

Longevity of life is not just about living longer, but extending the period of healthy and fulfilling living. Oral and hair health has a significant role to play in this. Concerns associated with tooth decay and loss and thinning of hair and baldness—often considered irreversible—are hindrances to long-term well-being and satisfaction.

OrganTech Inc is a leading Japanese biotechnology company pioneering the world’s first organ regenerative medical technology that redefines the way people approach oral and hair health.

It specializes in developing hair and dental regenerative medicine based on stem cells. The goal is to enhance long-term health satisfaction by focusing on solutions that enhance facial features.

“Our organ regeneration technology aims to address concerns related to tooth loss and thinning hair, promoting a healthier and more satisfying life,” says Miho Ogawa, representative director and co-CEO of OrganTech.

Founder Dr. Takashi Tsuji’s inspiration and insights were pivotal in shaping OrganTech’s direction. Unlike other academic approaches that rely on self-engineering, its foundation lies in embryology, setting it apart and enabling groundbreaking advancements in organ regeneration. Its core technology— unparalleled in the realm of regenerative medicine—is rooted in published research, which renders added reliability and robustness to its approach.

The company acknowledges the intricate connection between oral health, hair appearance, and the overall well-being of a person. Research has shown that tooth loss and related difficulties in chewing can increase the risk of conditions such as dementia, stroke, heart disease, and diabetes.

OrganTech’s groundbreaking approach to tooth regeneration aims to reconstruct periodontal tissue around dental implants, restoring the teeth’s natural function. Unlike conventional implants fixed to the jawbone, causing problems with occlusion and sensation, its solution promises customizable teeth, resistant to cavities.

Its approach brings similar advances in the realm of hair regeneration. Thinning hair can profoundly impact one’s self-image, and the technology developed by OrganTech aims to provide a fundamental treatment for hair loss. By cultivating and amplifying healthy stem cells, it can produce a larger quantity of hair follicles that, when transplanted, could restore hair growth and shine, helping hair follicle regeneration to treat patients with alopecia.

These innovations not only focus on infection prevention and oral hygiene but also improve sensory functions, ultimately enhancing an individual’s quality of life.

Leveraging Japan’s favorable regulatory framework, these advancements are on track for human clinical trials within the next 12-18 months, providing a significant R&D edge over its global counterparts.

OrganTech’s future plans include paving the way for advanced regenerative methods in the kidneys, stomach and auditory organs like outer, middle, and inner ear.

“We strive to transform these advancements into valuable services and products. Our commitment extends to exploring and commercializing other groundbreaking innovations in organ regenerative technologies in the years ahead,” says Takashi Kondo, representative director and co-CEO of OrganTech.

The company’s dedication to pioneering unique technologies extends to its partnership with universities, laboratories, and academics to identify cutting-edge innovations for future commercialization.

OrganTech’s journey into organ regeneration and health-related biotech innovations redefines oral health and hair loss solutions. With a blend of science, technology, and visionary leadership, it stands at the forefront of a revolution pushing boundaries and promising a healthier and more fulfilling life.